Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
AstraZeneca's Asthma Maintenance Treatment Gets EU Approval

AstraZeneca's Asthma Maintenance Treatment Gets EU Approval

MT newswireMT newswire2026/09/23 08:14
04:14 AM EDT, 09/23/2026 (MT Newswires) -- AstraZeneca (AZN) has received approval for the single-inhaler Trixeo Aerosphere in the European Union as a maintenance treatment for asthma in certain patients aged at least 12 years, the company said Wednesday. The approval covers patients who are not adequately controlled by a combination of a medium dose inhaled corticosteroid and long-acting beta2-agonist, according to the company.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!